Board meeting on 29 October 2026 to consider Q2 results and interim dividend
Board meeting scheduled for Thursday, 29th October 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Thursday, 29th October 2026
- Agenda
- unaudited financial results for quarter and nine months ended 30th September 2026; interim dividend, if any, for FY 2026
- Trading Window Closure
- from 1st October 2026 till 48 hours after the results are announced
Board meeting set for 29 October 2026
The company has informed both BSE (Scrip Code 500674) and NSE (Symbol SANOFI) that a meeting of its Board of Directors is scheduled for Thursday, 29th October 2026. The intimation was dated 19th October 2026.
Two items are on the agenda
- Consider and approve the unaudited financial results for the quarter and nine months ended 30th September 2026.
- Consider, declare and approve an interim dividend, if any, for the financial year 2026.
What the dividend item means
- The Board will take up an interim dividend for the current financial year at this meeting.
- The notice uses the words "if any", so the decision on whether a dividend is declared, and its amount, would be known once the Board meets.
- For a shareholder, an interim dividend is a payout decided during the year rather than at the annual general meeting.
Trading window
- The trading window for dealing in the company's shares stays closed from 1st October 2026 till 48 hours after the results are announced to the stock exchanges.
- This is the quiet period the company keeps around its results, and it applies to those covered by its insider trading rules.
What to watch
- The results for the quarter and nine months ended 30th September 2026, as approved by the Board, along with the dividend decision taken at the same meeting.
- A board meeting intimation is a scheduling notice. It tells investors when to expect the numbers and the dividend decision; it does not by itself contain the results or the dividend amount.
Also from Sanofi India
Promoter group entity acquires 3,500,000 shares (15.20%) from a promoter in inter-se transfer
7 Oct 2026
GST Show Cause Notice of Rs.16,40,07,641 received for FY 2022-23
29 Sep 2026
Promoter group inter-se transfer: 35,00,000 shares (15.20%) move from Hoechst GmbH to Sanofi Healthcare India
28 Sep 2026
More numbers
- Trading window closed till 48 hours after results are announced48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.